VKTX icon

Viking Therapeutics

114 hedge funds and large institutions have $76.5M invested in Viking Therapeutics in 2022 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 25 increasing their positions, 43 reducing their positions, and 42 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

less ownership

Funds ownership:

less capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding:

42% less repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 43

57% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 42

Holders
114
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.49M
Puts
$311K
Net Calls
Net Calls Change

Top Buyers

1 +$7.64M
2 +$3.83M
3 +$955K
4
Morgan Stanley
Morgan Stanley
New York
+$881K
5
IC
Ikarian Capital
Texas
+$875K

Top Sellers

1 -$10.7M
2 -$3.17M
3 -$1.75M
4
Northern Trust
Northern Trust
Illinois
-$1.51M
5
Citadel Advisors
Citadel Advisors
Florida
-$1.42M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$9.63M
2
$7.64M
3
$7.13M
4
$4.12M
5
$3.83M
6
$3.8M
7
$3.71M
8
$3.24M
9
$3.01M
10
$2.89M
11
$2.5M
12
$2.41M
13
$1.98M
14
$1.91M
15
$1.34M
16
$958K
17
$955K
18
$954K
19
$855K
20
$849K
21
$771K
22
$754K
23
$696K
24
$644K
25
$591K